• Mon news: Takeda layoffs. Novo’s semaglutide cardiovascular win. Roche’s Vabysmo in DME. Gilead/Merck HIV combo. Supernus quick-acting depression med. See more on our front page

CVAS overlay rep-job stability?

Keep in mind most AZ products lose exclusivity sp? much soon than Brillinta and the company has a lot of stock in it for the future of AZ. This is why they hired more reps and co-promote with the medicines company. Brillintas patent is the longest so one would think that anyone selling Brillinta is actually the safest.

Now that we are beginning 2013, what do you think about this position? Job is safe for at least 2-3 years? Brilinita has the longest patent of all AZ promoted products. Will generic plavix and ObamaCare halt any growth potential?